Serum Institute Starts Phase 2 Trial Of Oxford COVID-19 Vaccine Candidate Today
Pune: Serum Institute of India’s (SII) phase 2 trial of Oxford's COVID-19 vaccine candidate is set to commence on Tuesday.
The determination of safety and immunogenicity of “Covishield” on healthy Indian adults will start at Bharati…